False positive 131I whole body scans in thyroid cancer

British Journal of Radiology

Volumn 73, Issue 870, 2000, Pages 627-635

  Mitchell, G ^a   Pratt, B E ^a   Vini, L ^a   McCready, V R ^a   Harmer, C L ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 131; THYROGLOBULIN; DIAGNOSTIC AGENT; RADIOACTIVE IODINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DIAGNOSTIC ERROR; FOLLICULAR CARCINOMA; HUMAN; INFECTION; INFLAMMATION; IODINE 131 UPTAKE TEST; THYROID CARCINOMA; THYROIDECTOMY; WHOLE BODY SCINTISCANNING; BLOOD; CASE REPORT; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; LABORATORY DIAGNOSIS; MALE; METABOLISM; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PROTEIN BINDING; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THYROID TUMOR;

ADOLESCENT; ADULT; AGED; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; IODINE RADIOISOTOPES; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PROTEIN BINDING; SENSITIVITY AND SPECIFICITY; THYROGLOBULIN; THYROID NEOPLASMS; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0033623871     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr.73.870.10911786     Document Type: Article

References (37)

1. Harmer CL, McCready VR. Thyroid cancer: differentiated carcinoma. Cancer Treatment Rev 1996;22:161-77.
2. Bakheet SM, Hammami MM. False-positive radioiodine whole-body scan in thyroid cancer patients due to unrelated pathology. Clin Nucl Med 1994; 19:325-9.
3. 131I uptake in a benign serous cystadenoma of the ovary. Eur J Nucl Med 1984;9:433-5.
4. Brachman MB, Rothman BJ, Ramanna L, Tanasescu DE, Adelberg H, Waxman AD. False-positive iodine-131 whole-body scan caused by a large renal cyst. Clin Nucl Med 1988;13:416-8.
5. Greenler DP, Klein HA. The scope of false-positive iodine-131 images for thyroid carcinoma. Clin Nucl Med 1989;14:111-7.
6. Rosenbaum RC, Johnston GS, Valante WA. Frequency of hepatic visualisation during I-131 imaging for metastatic thyroid carcinoma. Clin Nucl Med 1988;13:657-60.
7. Hammami MM, Bakheet S. Radioiodine breast uptake in non-breastfeeding women: clinical and scintigraphic characteristics. J Nucl Med 1996;37: 26-31.
8. Vermiglio F, Baudin E, Travagli JP, Caillou B, Fragu P, Ricard M, et al. Iodine concentration by the thymus in thyroid carcinoma. J Nucl Med 1996; 37:1830-1.
9. Black EG, Cassoni A, Gimlette TMD, Harmer CL, Maisey MN, Oates GD, et al. Serum thyroglobulin in thyroid cancer. Lancet 1981;2:443-5.
10. Harmer CL. Radiotherapy in the management of thyroid cancer. Ann Acad Med Singapore 1996;25: 413-9.
11. Ramanna L, Waxman AD, Brachman MB, Sensel N, Tanasescu DE, Berman DS, et al. Correlation of thyroglobulin measurements and radioiodine scans in the follow-up of patients with differentiated thyroid cancer. Cancer 1985:55:1525-9.
12. Brown AP, Greening WP, McCready VR, Shaw HJ, Harmer CL. Radioiodine treatment of metastatic thyroid carcinoma: the Royal Marsden Hospital experience. Br J Radiol 1984;57:323-7.
13. Roti E, Minelli R, Gardini E, Braverman LE. The use and misuse of thyroid hormone. Endocr Rev 1993;14:401-23.
14. Ozata M, Suzuki S, Miyamoto T, Liu RT, Fierro-Renoy F, DeGroot LJ. Serum thyroglobulin in the follow-up of patients with treated differentiated thyroid cancer. J Clin Endocrinol Metab 1994;79: 98-105.
15. Hjiyiannakis D, Munday J, Harmer CL. Thyroglobulin antibodies in differentiated thyroid cancer. Clin Oncol 1999;11:240-4.
16. Harmer CL, Tyrell CJ, McCready VR. Uptake of isotope in residual normal thyroid tissue following I-131 ablation for carcinoma. In: Book of abstracts, XIV Congresso International de Radiologica; 1977; Rio de Janeiro. National Organising Committee of the XIV International Congress of Radiology Rio Meeting:562.
17. Tyson JW, Wilkinson RH, Witherspoon LR, Goodrich JK. False-positive I-131 total body scans. J Nucl Med 1974;15:1052-3.
18. Robertson JS, Verhasselt M, Wahner HW. Use of I-123 for thyroid uptake measurements and depression of I-131 thyroid uptake by incomplete dissolution of capsule filter. J Nucl Med 1974;15: 770-4.
19. Caplan RH, Gunderson GA, Abellera M, Kisken WA. Uptake of iodine-131 by a Meckel's diverticulum mimicking metastatic thyroid cancer. Clin Nucl Med 1987;12:760-2.
20. Fernandez-Ulloa M, Maxon HR. Mehta S, Sholiton LJ. Iodine-131 uptake by primary lung adenocarcinoma, misinterpretation of 131-I scan. J Am Med Assoc 1976;236:857-8.
21. Brucker-Davis F, Reynolds JC, Skarulis MC, Fraker DL, Alexander HR, Weintraub BD. et al. False-positive iodine-131 whole-body scans due to cholecystitis and sebaceous cyst. J Nucl Med 1996; 37:1690-3.
22. Echenique R, Kasi L, Haynie TP, Glenn HJ, Samaan NA, Stratton Hill C. Critical evaluation of serum thyroglobulin levels and I-131 scans in post-therapy patients with differentiated thyroid carcinoma: concise communication. J Nucl Med 1982;23:235-40.
23. Hoschl R, Choy DHL, Gandevia B. Iodine-131 uptake in inflammatory lung disease: a potential pitfall in treatment of thyroid carcinoma. J Nucl Med 1988;29:701-3.
24. Yeh E-L, Meade RC, Ruetz PP. Radionuclide study of struma ovarii. J Nucl Med 1973;14:118-21.
25. Lakshmanan M, Reynolds JC, Del Vecchio S, Merino MJ, Norton JA, Robbins J. Pelvic radioiodine uptake in a rectal wall teratoma after thyroidectomy for papillary carcinoma. J Nucl Med 1992;33:1848-50.
26. Acosta J, Chitkara R, Khan F, Azueta V, Silver L. Radioactive iodine uptake by a large-cell undifferentiated bronchogenic carcinoma. Clin Nucl Med 1982;7:368-9.
27. Wu SY, Kollin J, Coodley E, Lockyer T, Lyons KP, Moran E, et al. Iodine-131 total-body scan: localisation of disseminated gastric adenocarcinoma. Case report and survey of the literature. J Nucl Med 1984;25:1204-9.
28. Baeumler GR, Joo KG. Radioactive iodine uptake by breasts. J Nucl Med 1986;27:149-50.
29. Zeissman HA, Bahar H, Fahey FH, Dubiansky V. Hepatic visualisation on iodine-131 whole-body thyroid cancer scans. J Nucl Med 1987;28:1408-11.
30. 131I (i.e. it does not cause stunning) in differentiated thyroid cancer. Nucl Med Commun 1997;18:505-12.
31. Jackson GL, Flickinger FW, Graham WP, Kennedy TJ. Thymus accumulation of radioactive iodine. Pennsylvania Med 1979;11:37-8.
32. Veronikis IE, Simkin P, Braverman LE. Thymic uptake of iodine-131 in the anterior mediastinum. J Nucl Med 1996;37:991-2.
33. 131I therapy for thyroid carcinoma: a trap for the unwary? Nucl Med Commun 1997;18:288-9.
34. Park HM, Park YH, Zhou XH. Detection of thyroid remnant/metastases without stunning: an ongoing dilemma. Thyroid 1997;7:277-80.
35. Grunwald F, Menzel C, Bender H, Palmedo H, Willkomm P, Ruhlmann J, et al. Comparison of 18FDG-PET with 131-iodine and 99mTc-sestamibi scintigraphy in differentiated thyroid cancer. Thyroid 1997;7:327-35.
36. Jones T. The role of positron emission tomography within the spectrum of medical imaging. Eur J Nucl Med 1996;23:207-11.
37. Piwinica-Worms D, Kronauge JF, Chiu ML. Uptake and retention of hexakis (2-methoxyisobutyl isonitril) technetium (I) in cultured chick myocardial cells, mitochondrial and plasma membrane dependence. Circulation 1990;82:1826-38.